If you are curious about what those first weeks feel like, the initial experience on semaglutide varies considerably from person to person, though most people notice appetite suppression within the first one to two weeks
While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy
The privacy of the consumers is also being maintained, which is increasing their use
Most people lose 5-10% of their initial weight on these medications
Hair follicles are metabolically active structures with high nutritional demands, and deficiencies in these micronutrients can compromise the hair growth cycle
Commercial plan coverage varies more widely and may provide MNT counseling for obesity but with annual or lifetime limits